Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,186,600 | 726,800 | 709,200 | 714,100 | 1,261,300 |
| Marketable Securities | 170,300 | 207,500 | 253,800 | 242,400 | 334,400 |
| Receivables | 570,000 | 609,600 | 578,000 | 537,300 | 530,100 |
| Inventories | 611,100 | 624,900 | 630,900 | 607,000 | 583,800 |
| Other current assets | 144,400 | 130,200 | 141,500 | 131,800 | 150,400 |
| TOTAL | $2,739,700 | $2,354,700 | $2,368,800 | $2,286,900 | $2,912,600 |
| Non-Current Assets | |||||
| PPE Net | 973,600 | 931,100 | 892,200 | 867,500 | 826,100 |
| Investments And Advances | 386,000 | 412,900 | 453,700 | 0 | 479,000 |
| Intangibles | 1,537,700 | 1,559,500 | 1,444,700 | 1,455,400 | 1,590,200 |
| Other Non-Current Assets | 329,300 | 315,300 | 309,900 | 713,900 | 150,300 |
| TOTAL | $3,226,600 | $3,218,800 | $3,100,500 | $3,036,800 | $3,045,600 |
| Total Assets | $5,966,300 | $5,573,500 | $5,469,300 | $5,323,700 | $5,958,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 599,900 |
| Accounts payable and accrued liabilities | 751,700 | 673,200 | 623,900 | 134,000 | 661,200 |
| Accrued Expenses | N/A | N/A | N/A | 742,600 | N/A |
| TOTAL | $775,800 | $697,000 | $646,500 | $876,600 | $1,261,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 594,200 | 594,100 | 593,900 | 593,800 | 593,600 |
| aiOther Non-Current Liabilities | 781,500 | 782,100 | 781,400 | 712,900 | 742,200 |
| TOTAL | $1,375,700 | $1,376,200 | $1,375,300 | $1,306,700 | $1,335,800 |
| Total Liabilities | $2,151,500 | $2,073,200 | $2,021,800 | $2,183,300 | $2,596,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 625,710 | 623,908 | 625,505 | 623,299 | 627,148 |
| Common Shares | 217,500 | 216,900 | 216,000 | 215,200 | 214,800 |
| Retained earnings | 3,461,400 | 3,186,700 | 2,944,400 | 2,694,700 | 2,687,700 |
| Other shareholders' equity | -155,500 | -138,600 | -141,300 | -138,900 | -139,400 |
| TOTAL | $3,814,800 | $3,500,300 | $3,447,500 | $3,140,400 | $3,361,300 |
| Total Liabilities And Equity | $5,966,300 | $5,573,500 | $5,469,300 | $5,323,700 | $5,958,200 |